BackLarimar Therapeutics Overview
Larimar Therapeutics Inc

Larimar Therapeutics Target Price

Where could LRMR trade next? Consensus target price: $5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.11

Average Target Price

$5.0021.7% upside

1 analysts in the last 4 months

High: $5 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-30Robert W. BairdChristopher Chen$521.7% upsideOpen
2026-03-03WedbushLaura Chico$12192% upsideOpen
2025-09-30Robert W. BairdJoel Beatty$770.3% upsideOpen
2024-12-17H.C. WainwrightEdward White$15265% upsideOpen
2024-10-30CitigroupSamantha Semenkow$14240.6% upsideOpen
2024-10-03WedbushLaura Chico$22435.3% upsideOpen
2024-04-03Leerink PartnersJoori Park$25508.3% upsideOpen
2022-12-13Citigroup$42.7% downsideOpen

Larimar Therapeutics (LRMR) FAQ

As of the most recent data, LRMR shows a target price of $5. Scroll down for historical charts and peer comparison views.

If Larimar Therapeutics moved to the average analyst target of $5, shares would be roughly 21.7% higher than $4.11. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Larimar Therapeutics's earnings trajectory.

Besides this target price page, Stockcircle has Larimar Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $5) with ownership activity and broader fundamentals.

Larimar Therapeutics's target price is $5; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.